Literature DB >> 35248207

Cognitive dysfunction and neuropsychiatric aspects of Parkinson's disease.

Gabriela Austgen1, Laura Marsh2.   

Abstract

Movement abnormalities, by definition, and cognitive changes, to varying extents, affect every patient with Parkinson's disease (PD) and are attributed to the underlying neurodegenerative disease. Various psychiatric disorders occur in most patients at some point over the course of PD, including in the prodromal phase. Even though psychiatric disturbances tend to aggravate motor and cognitive deficits, they are under-recognized and under-treated, and the role of the underlying neurological disease is often minimized. To provide an integrated approach to understanding neuropsychiatric aspects of PD, this chapter reviews how cognitive changes in PD relate to the common psychiatric disturbances in PD along with the prevalence, phenomenology, pathophysiology, and treatment of each.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Apathy; Delusions; Depression; Hallucinations; Impulse control disorders; Major depression; Non-major depression; Psychiatric disorder; Psychosis

Mesh:

Year:  2022        PMID: 35248207     DOI: 10.1016/bs.pbr.2022.01.009

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  1 in total

1.  CB2 Agonist GW842166x Protected against 6-OHDA-Induced Anxiogenic- and Depressive-Related Behaviors in Mice.

Authors:  Xiaojie Liu; Hao Yu; Bixuan Chen; Vladislav Friedman; Lianwei Mu; Thomas J Kelly; Gonzalo Ruiz-Pérez; Li Zhao; Xiaowen Bai; Cecilia J Hillard; Qing-Song Liu
Journal:  Biomedicines       Date:  2022-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.